Skip to content
Institutional Investor Seed Series A Series B Series C Est. 2021

Monograph

Venture capital firm focused on life sciences companies

📍 London, United Kingdom

About This Fund

Venture capital firm focused on life sciences companies. It seeks to create improved therapeutics, diagnostics, and related technology-enabled business services that enhance healthcare outcomes.

Investment Focus

Sectors
life sciences therapeutics diagnostics pharma services biotech digitally-enabled healthcare services
Stages
Seed Series A Series B Series C
Check Size $3M-$10M
Geography
USA UK Europe

What They Look For

Innovative companies translating promising science into life-changing treatments; strong teams with expertise bridging research to application; clear path from discovery to patient impact with clinical validation, regulatory strategy, pharma partnerships; primarily North America, UK, Europe

Preparing to pitch Monograph?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →